PharVision Advisers’s Devon Energy DVN Stock Holding History

PharVision Advisers’s Portfolio DVN Stock Details DVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,900	Closed	-$219K	–	696
2025 Q2	$219K	Buy	+6,900	New	+$220K	0.32%	175

Other funds holding DVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

EECFX

EnCap Energy Capital Fund XI Houston, Texas $1.14B AUM 5.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EnCap Partners Houston, Texas $383M AUM 10.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PharVision Advisers's DVN Position: Q3 2025 in Review

PharVision Advisers sold out of Devon Energy (DVN) in Q3 2025, closing a stake of 6,900 shares — an estimated $219K sold.

PharVision Advisers first reported a position in DVN in Q2 2025 and held it in 1 quarter. The position peaked at $219K in Q2 2025. 1,102 funds tracked by Wall St. Rank hold DVN as of Q3 2025.

PharVision Advisers reported no remaining Devon Energy position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 6,900 Devon Energy shares in Q3 2025, an estimated $219K.
PharVision Advisers first reported a position in Devon Energy in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Devon Energy position peaked at $219K in Q2 2025.
1,102 funds tracked by Wall St. Rank held Devon Energy as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.